Related Experiment Video
Updated: Aug 7, 2026
05:14
Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra
Published on: September 8, 2021
Fewer but heavier caffeine consumers in schizophrenia: a case-control study
Manuel Gurpegui1, M Carmen Aguilar, José M Martínez-Ortega
1Department of Psychiatry and Institute of Neurosciences, University of Granada Medical School, Av Madrid 11, Granada, Spain. gurpegui@ugr.es
Schizophrenia Research
|June 21, 2006
Summary
Schizophrenia patients consume caffeine less frequently overall, but heavy caffeine intake is more common in those with schizophrenia, especially when combined with smoking. This association is partly explained by smoking
Area of Science:
- Psychiatry and Behavioral Science
- Neuroscience
- Pharmacology
Background:
- Existing literature suggests a link between schizophrenia and caffeine consumption.
- Clarity is lacking on whether schizophrenia involves higher caffeine intake prevalence or quantity.
- Controlling for demographic variables, tobacco, and alcohol use is crucial for accurate analysis.
Purpose of the Study:
- To compare caffeine consumption patterns in schizophrenia patients versus a control group.
- To investigate the relationship between schizophrenia, caffeine intake, and co-occurring substance use.
- To explore potential pharmacokinetic interactions, particularly with smoking.
Main Methods:
- Comparison of schizophrenia patients (n=250) with a control sample (n=290).
- Statistical control for demographic variables, tobacco, and alcohol consumption.
- Multivariate analyses to assess caffeine intake frequency and amount.
Main Results:
- Schizophrenia patients showed less frequent overall caffeine intake (59%) compared to controls (70%).
- Heavy caffeine intake (≥200 mg/day) was significantly associated with schizophrenia (64% vs. 36%).
- Smoking and older age were associated with heavy caffeine intake in both groups; daily caffeine and cigarette amounts correlated in schizophrenia patients.
Conclusions:
- While overall caffeine use is lower in schizophrenia, heavy consumption is more prevalent.
- The association between schizophrenia and heavy caffeine intake is partly mediated by smoking.
- Pharmacokinetic interactions, like smoking-induced caffeine metabolism, may influence these relationships.
Related Concept Videos
01:29Biological Causes of Schizophrenia
Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin studies.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin studies.
01:24Substance Use Disorders Affecting Sleep
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
Understanding the concepts of physical dependence,...
01:30Attention-Deficit/Hyperactivity Disorder
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.
01:16Experimental Designs
An experimental design is a systematic process that allows researchers to evaluate the relationship between dependent and independent variables. There are three widely used types of experimental design - pre-experimental design, true experimental design, and quasi-experimental design. In pre-experimental design, the researcher compares the data before and after some interventions or treatments. The true-experimental design has more than one purposefully created group, a commonly measured...
01:23Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
01:08Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...